Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control

Diabetes mellitus and the associated complications represent a global burden on human health and economics. Cardiovascular diseases are the leading cause of death in diabetic patients, who have a 2–5 times higher risk of developing heart failure than age-matched non-diabetic patients, independent of...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Giulia Borghetti, Dirk von Lewinski, Deborah M. Eaton, Harald Sourij, Steven R. Houser, Markus Wallner
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2018-10-01
Serija:	Frontiers in Physiology
Teme:	diabetic cardiomyopathy anti-hyperglycemic drug SGLT-2 inhibitors incretin-based therapy heart failure pathogenesis
Online dostop:	https://www.frontiersin.org/article/10.3389/fphys.2018.01514/full
Oznake:	Označite Brez oznak, prvi označite!